Boston Red Sox pitcher Nick Pivetta

...

Zach Pressnell

By Zach Pressnell

Contributing Sports Writer

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


The Atlanta Braves were rumored to be among the favorites to land Max Scherzer, but Scherzer ended up signing a deal with the Toronto Blue Jays.

With Atlanta seeing both Charlie Morton and Max Fried part ways with the franchise this winter, the Braves could have used a pitcher like Scherzer. But with him off the board, Atlanta is going to need to pursue a different free agent starter.

FanSided's Cody Williams recently linked the Braves to Boston Red Sox free agent pitcher Nick Pivetta. Pivetta is projected to land a deal worth $60 million in free agency, per Spotrac.

Read More on MLB

Boston Red Sox pitcher Nick Pivetta

...

"It's always worth noting that the Braves don't need a No. 1 or No. 2 starter," Williams wrote. "While no one in Atlanta would turn that down if it happened organically, it's simply not necessary with what we can reasonably expect from Sale and Lopez at the top. Perhaps the bigger question is if the club would feel more confident in Schwellenbach as the No. 3 or 4 option in the rotation.

"Nick Pivetta could be the middle ground there. The Braves have done an overall excellent job in developing pitchers and getting the best out of them in many capacities. Depending on the price tag for Pivetta, that could absolutely be a worthwhile risk for Atlanta, especially when only inserting him into the back end of this rotation."

Pivetta may not be able to follow in the footsteps of the longtime Brave, Max Fried, but the righty could take the role that was held by Morton in 2024.

The Braves wouldn't need Pivetta to come in and be an ace. They already have quite a few pitchers to handle that role. But Atlanta needs depth and Pivetta might be exactly what it needs.

More MLB: Jack Flaherty Predicted To Betray Dodgers, Sign Massive Deal With Crosstown Rival

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines